|
Pyxant
Labs Inc.
Bioanalytical
Methods
Analyte |
Species |
Matrix |
LLOQ
(ng/mL) |
ULOQ
(ng/mL) |
Sample
Volume (µL) |
Instrumentation |
Phenytoin |
Human |
Plasma |
50.0 |
5000 |
250 |
LC/MS/MS |
Valproic Acid |
Human |
Serum |
1000 |
100,000 |
50.0 |
LC/MS/MS |
Glyburide |
Human |
Plasma |
2.00 |
2000 |
50.0 |
LC/MS/MS |
Telmisartan |
Human |
Plasma |
0.5 |
5000 |
25.0 |
LC/MS/MS |
Budesonide |
Human |
Plasma |
0.01 |
0.750 |
150 |
LC/MS/MS |
Granisetron |
Human |
Plasma |
0.0500 |
50.0 |
200 |
LC/MS/MS |
| Valdecoxib |
Human |
Plasma |
0.300 |
300 |
500 |
LC/MS/MS |
| Hydrochlorothiazide |
Human |
Plasma |
1 |
250 |
300 |
LC/MS/MS |
Scopolamine |
Human |
Plasma |
0.0020 |
2 |
125 |
LC/MS/MS |
Bioanalytical Methods
In Development
Analyte |
Species |
Matrix |
LLOQ
(ng/mL) |
ULOQ
(ng/mL) |
Sample
Volume (µL) |
Instrumentation |
Amlodipine |
|
|
|
|
|
|
Candesartan |
|
|
|
|
|
|
Ciprofloxacin |
|
|
|
|
|
|
Digoxin |
|
|
|
|
|
|
| Dipyridamole |
|
|
|
|
|
|
| Moxifloxacin |
|
|
|
|
|
|
| Sildenafil |
|
|
|
|
|
|
| Tadalafil |
|
|
|
|
|
|
| Vardenafil |
|
|
|
|
|
|
| Warfarin |
|
|
|
|
|
|
Copyright
Pyxant Labs 2004 All rights reserved
|
